VANC Receives Recommendation from Glass Lewis

VANCOUVER, British Columbia, Sept. 07, 2017 (GLOBE NEWSWIRE) — VANC Pharmaceuticals Inc. (the “VANC” or the “Company”) (TSX-V:VANC) (OTCQB:NUVPF), a pharmaceutical company focused on the Canadian generic drug and over-the-counter (the “OTC”) markets, announced...